The global in situ hybridization (ISH) market size is expected to reach USD 1.84 billion by 2025, according to a new report by Grand View Research, Inc., registering a 7.3% CAGR during the forecast period. Increasing demand for molecular diagnostic tools in clinical research and diagnosis is anticipated to fuel demand for ISH in the coming years. Real-time and automated diagnostic kits for accurate and rapid diagnosis of cytogenetic modifications is boosting the growth prospects of the market.
Market
penetration of Fluorescent In Situ Hybridization (FISH) probe in cancer
diagnostics is the highest in the current scenario, which is contributing to
its largest revenue share. Increasing R&D pertaining to the application of
ISH in genetic diseases and testing of infectious diseases is expected to drive
the market in the near future. For instance, in 2016, Oxford Gene Technology
expanded its portfolio of Cytocell Aquarius FISH probes for pathology.
For Full Research Report On In Situ Hybridization Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/in-situ-hybridization-ish-market
In Situ
Hybridization Market Report Highlights
- FISH held the dominant share
in terms of revenue as of 2016 owing to increase in its application in
molecular diagnostics
- The DNA probes segment
accounted for the largest revenue share owing to extensive usage in
clinical research and diagnosis
- RNA probes are expected to
witness lucrative CAGR in the coming years due to advantages associated
with their use such as increased stability and low cost
- ISH services are anticipated
to witness exponential growth over the forecast period owing to increase
in demand for outsourcing of molecular biology services by researchers and
pathologists
- At present, the adoption of
ISH in cancer diagnostics held the dominant revenue share due to
widespread application of ISH probe technology in cancer research and
diagnosis
- Contract research
organizations are expected to exhibit fastest growth during the forecast
period owing to rising demand for molecular and cytogenetic services in
clinical studies
- Research and diagnostic
laboratories accounted for the largest revenue share as these systems are
most commonly used in diagnosis and research studies for the detection of
chromosomal abnormalities in various disease conditions
- North America held a
majority share of the revenue due to presence of well-established
diagnostic companies, coupled with high adoption of molecular diagnostic
tools by researchers in this region
- Asia Pacific is expected to
exhibit lucrative growth owing to increase in investments by governments
to support the growth of the biotechnology sector
- The market is facing
extensive competition as there are a large number of players offering ISH
probe technology for various applications.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/in-situ-hybridization-ish-market/request/rs1
In Situ
Hybridization Market Segmentation
Grand View Research has segmented
the global In Situ Hybridization (ISH) market on the basis of technology, type,
product, application, end use, and region:
In Situ
Hybridization (ISH) Technology
Outlook (Revenue, USD Million, 2014 - 2025)
- Fluorescent In Situ
Hybridization (FISH)
- Chromogenic In Situ
Hybridization (CISH)
In Situ
Hybridization (ISH) Type
Outlook (Revenue, USD Million, 2014 - 2025)
- DNA
- RNA
In Situ
Hybridization (ISH) Product
Outlook (Revenue, USD Million, 2014 - 2025)
- Instruments
- Kits & Probes
- Software
- Services
In Situ
Hybridization (ISH) Application
Outlook (Revenue, USD Million, 2014 - 2025)
- Cancer
- Cytogenetics
- Developmental Biology
- Infectious Diseases
- Others
In Situ
Hybridization (ISH) End-use
Outlook (Revenue, USD Million, 2014 - 2025)
- Research & Diagnostic
Laboratories
- Contract Research
Organizations (CROs)
- Academic Institutes
- Others
In Situ
Hybridization (ISH) Regional
Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based
market research and consulting company, registered in the State of California
and headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment